Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Everfront Biotech Co., Ltd.

Clinical trials sponsored by Everfront Biotech Co., Ltd., explained in plain language.

Everfront Biotech Co., Ltd. EFB NASDAQ

A biotech company developing treatments for central nervous system disorders.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1

New brain cancer wafer shows promise in recurrent glioblastoma trial

Disease control Not yet recruiting

This study tests a new treatment called Cerebraca Wafer for people with recurrent glioblastoma, a serious brain cancer. The wafer is placed in the brain during surgery and is followed by standard chemotherapy. The goal is to see if it helps people live longer and controls the dis…

Phase: PHASE2, PHASE3 • Sponsor: Everfront Biotech Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC